Actively Recruiting
Study and Modeling of Perforator Flap Vascularization
Led by University Hospital, Montpellier · Updated on 2026-04-13
20
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of reconstructive surgery is to restore physical integrity altered by trauma, congenital malformations or cancerous pathologies. Several techniques are available, including flap surgery, which enables tissue to be moved from one anatomical location to another. Perforating skin/subcutaneous flaps are segments of skin and subcutaneous cellular tissue vascularized by a feeder vascular pedicle. This surgical technique has virtually zero donor-site morbidity, as it is no longer necessary to harvest muscle to ensure reliable vascularization of the flap. Flap vascularization is a variable mechanism, complex to describe and understand. For cutaneous and subcutaneous (fatty) flaps, which account for the majority of flaps used, perforator flaps (vascularized by a subcutaneous perforator artery) have become the benchmark. Unfortunately, their vascularization is currently poorly understood, and depends on experimental work carried out on fresh cadaveric anatomical specimens. These cadaveric studies fail to take into account several key factors influencing perforasomes (perforasome: skin territory vascularized by a pedicle), namely body temperature, blood pressure, heart rate, intraoperative patient position and biological parameters.
CONDITIONS
Official Title
Study and Modeling of Perforator Flap Vascularization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 70
- Undergoing reconstructive surgery using pedicled or free perforating flap
- Flap has a surface area of at least 50 cm2 for good perfusion visualization
- For pedicled perforating flaps: patient has pelvic eschar
- For free perforating flaps: patient has traumatic pathology of lower and/or upper limb
You will not qualify if you...
- No consent obtained
- No social security affiliation
- Persons under court protection
- Persons participating in another study with an exclusion period still in progress
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Montpellier
Montpellier, France, 34000
Actively Recruiting
Research Team
C
Christian HERLIN, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here